DOI:
10.1055/s-00000011
DMW - Deutsche Medizinische Wochenschrift
LinksClose Window
References
Shi Q, Sobrero A, Shields AF. et al.
Prospective pooled analysis of six phase III trials investigating duration of adjuvant (adjuv) oxaliplatin-based therapy (3 vs 6 months) for patients (pts) with stage III colon cancer (CC).
J Clin Oncol 2017
35. Supplement; abstr LBA1
Access:
We do not assume any responsibility for the contents of the web pages of other providers.